2022
- Bosma KJ, Ghosh M, Andrei SR, Zhong L, Dunn JC, Ricciardi VF, Burkett JB, Hatzopoulos AK, Damron DS, Gannon M. Pharmacological modulation of prostaglandin E (PGE ) EP receptors improves cardiomyocyte function under hyperglycemic conditions. Physiological reports. 2022 Dec 1; e15212.
2021
- Snider JC, Riley LA, Mallory NT, Bersi MR, Umbarkar P, Gautam R, Zhang Q, Mahadevan-Jansen A, Hatzopoulos AK, Maroteaux L, Lal H, Merryman WD. Targeting 5-HT Receptor Signaling Prevents Border Zone Expansion and Improves Microstructural Remodeling After Myocardial Infarction. Circulation. 2021 Dec 30; 1317-1330. NIHMSID: NIHMS1673297.
- Summers ME, Richmond BW, Kropski JA, Majka SA, Bastarache JA, Hatzopoulos AK, Bylund J, Ghosh M, Petrache I, Foronjy RF, Geraghty P, Majka SM. Balanced Wnt/Dickkopf-1 signaling by mesenchymal vascular progenitor cells in the microvascular niche maintains distal lung structure and function. American journal of physiology. Cell physiology. 2021 Dec 1; C119-C131.
2020
- Raucci FJ, Singh AP, Soslow J, Markham LW, Zhong L, Aljafar W, Lessiohadi N, Awgulewitsch CP, Umbarkar P, Zhang Q, Cannon PL, Buchowski M, Roland JT, Carrier EJ, Burnette WB, Hatzopoulos AK, Lal H, Galindo CL. The BDNF rs6265 Polymorphism is a Modifier of Cardiomyocyte Contractility and Dilated Cardiomyopathy. International journal of molecular sciences. 2020 Oct 10;
2019
- Hatzopoulos AK. Disease Models & Mechanisms in the Age of Big Data. Disease models & mechanisms. 2019 Dec 20;
- Schroer AK, Bersi MR, Clark CR, Zhang Q, Sanders LH, Hatzopoulos AK, Force TL, Majka SM, Lal H, Merryman WD. Cadherin-11 blockade reduces inflammation-driven fibrotic remodeling and improves outcomes after myocardial infarction. JCI insight. 2019 Dec 19;
- Wu DH, Hatzopoulos AK. Bone morphogenetic protein signaling in inflammation. Experimental biology and medicine (Maywood, N.J.). 2019 Dec 1; 147-156.
2018
- Traverse JH, Henry TD, Pepine CJ, Willerson JT, Chugh A, Yang PC, Zhao DXM, Ellis SG, Forder JR, Perin EC, Penn MS, Hatzopoulos AK, Chambers JC, Baran KW, Raveendran G, Gee AP, Taylor DA, Moyé L, Ebert RF, Simari RD. TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis. Circulation research. 2018 Dec 2; 479-488. NIHMSID: NIHMS925090.
2017
- The Vascular Wall: a Plastic Hub of Activity in Cardiovascular Homeostasis and Disease. Current cardiology reports. 2017 Jun 1; 51 p.
- Coordinated Proliferation and Differentiation of Human-Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells Depend on Bone Morphogenetic Protein Signaling Regulation by GREMLIN 2. Stem cells and development. 2017 May 1; 678-693.
- Molecular, phenotypic, and sample-associated data to describe pluripotent stem cell lines and derivatives. Scientific data. 2017 Mar 28; 170030 p.
2016
- Instructive Role of the Microenvironment in Preventing Renal Fibrosis. Stem cells translational medicine. 2016 Oct 5.
- BMP Antagonist Gremlin 2 Limits Inflammation After Myocardial Infarction. Circulation research. 2016 Jul 22; 434-49. NIHMSID: NIHMS794908.
- Integrated Genomic Analysis of Diverse Induced Pluripotent Stem Cells from the Progenitor Cell Biology Consortium. Stem cell reports. 2016 Jul 12; 110-25.